Bluerock Therapeutics
Clinical trials sponsored by Bluerock Therapeutics, explained in plain language.
-
Experimental cell therapy aims to restore sight in rare eye diseases
Disease control Recruiting nowThis study tests a new treatment called OpCT-001 for people with inherited eye diseases like retinitis pigmentosa and Usher syndrome, which cause vision loss. The treatment involves injecting special cells into the eye to replace damaged light-sensing cells. The study has two par…
Phase: PHASE1, PHASE2 • Sponsor: BlueRock Therapeutics • Aim: Disease control
Last updated May 26, 2026 07:21 UTC
-
Brain cell transplant trial aims to ease Parkinson's symptoms
Disease control Recruiting nowThis phase 3 study tests a treatment called bemdaneprocel, which involves transplanting dopamine-producing nerve cells into the brains of people with Parkinson's disease. The goal is to reduce daily 'off' time when symptoms worsen and increase 'on' time with good movement control…
Phase: PHASE3 • Sponsor: BlueRock Therapeutics • Aim: Disease control
Last updated May 22, 2026 13:50 UTC